Today: 23 April 2026
LSEG share price ticks higher in early trade as investors eye Feb 26 results
17 February 2026
1 min read

LSEG share price ticks higher in early trade as investors eye Feb 26 results

London, Feb 17, 2026, 08:47 GMT — Regular session

  • LSEG inched up roughly 0.4% to 7,646p early on, hovering close to the session’s high.
  • Eyes are now on LSEG, which is set to release its preliminary results on Feb 26.
  • This week’s UK inflation and retail sales figures are set to influence rate-cut expectations as well as drive movement in London stocks.

Shares of London Stock Exchange Group (LSEG.L) edged up 0.4% to 7,646 pence as of 0839 GMT Tuesday, following a Monday close at 7,612 pence. During the morning session, trading ranged between 7,578 and 7,658 pence. The group’s market value sits near 38.3 billion pounds. Still, the stock remains far from its 52-week peak of 11,915 pence.

FTSE 100 ticked higher at the open, lifting some of the big financials. By 0811 GMT, the blue-chip index had gained 0.33%, sitting at 10,507.97, Investors Chronicle figures showed.

LSEG is up next with its preliminary full-year results for the period ended Dec. 31, landing Feb. 26. Also on the calendar: a Q1 trading update focused on revenue, plus the annual general meeting, both set for April 23.

European companies have been turning in decent earnings, but that hasn’t been enough to spark a broad rally—investors have zeroed in on guidance and where valuations sit. “Overall, EPS (earnings per share) recovery is on track, especially in Europe,” Barclays European equity strategist Magesh Kumar Chandrasekaran said. But with current valuations, “a bit more nervousness around earnings” tends to creep in, Deutsche Bank’s Carolin Raab added. Reuters

Macro data has the potential to rattle or reassure. Investors are watching UK January inflation and retail sales figures this week; money markets, according to Reuters on Monday, are currently betting on a 25-basis-point rate cut next month — that’s a quarter point.

With LSEG, investors usually zero in on the recurring revenue—data and analytics keep that engine running. They’re also watching trading and clearing volumes, tracking any changes as risk appetites move around.

Comparisons don’t do LSEG many favors—and they’re hardly straightforward. Most traders put it next to Deutsche Börse or Euronext, then go back and forth on the familiar metrics: index licensing, clearing profit margins, the stickiness of those data subscriptions.

But it swings both directions. If guidance for 2026 turns cautious, or volumes slip in a jittery market, shares can fall quickly. A stronger inflation print? That can delay rate-cut hopes, leaving valuations under strain.

Stock Market Today

  • Jim Cramer Eyes More Procter & Gamble Shares If Price Dips Below $140
    April 23, 2026, 1:10 PM EDT. On Thursday, Jim Cramer highlighted a market rotation from software to hardware as ServiceNow shares fell 17% post-earnings despite beating forecasts. Chip designer Arm led the hardware rally, surging 6% to record highs, though Cramer expressed concern over its CEO's expanded role at SoftBank. Investor attention turns to Procter & Gamble, which rose over 1% ahead of Friday's earnings. Cramer said he plans to "buy more" shares if the price falls below $140, praising new CEO Shailesh Jejurikar's international expertise. Analysts expect modest earnings per share growth near 1% and organic revenue growth below 2%, with eyes on cost pressures from higher resin prices, a packaging material derived from oil.

Latest article

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

23 April 2026
IREN shares jumped 7.3% to $51.94 in New York Thursday amid debate over its shift from bitcoin mining to AI cloud services. The company plans to deploy 150,000 Nvidia GPUs by late 2026 and reported $2.8 billion in cash as of January. AI cloud revenue remains small compared to bitcoin mining, with $17.3 million last quarter. IREN can sell up to $6 billion in stock under a new SEC filing.
Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

23 April 2026
Hims & Hers Health said Thursday its providers can now send prescriptions for Eli Lilly’s Zepbound and Foundayo to LillyDirect, expanding branded obesity drug options on its platform. The move follows a similar deal with Novo Nordisk in March. Hims listed Foundayo from $149 a month and Zepbound from $299. The company previously stopped advertising compounded GLP-1s amid tighter U.S. regulations.
Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

23 April 2026
Greg Abel now controls about 94% of Berkshire Hathaway’s $300 billion stock portfolio after Todd Combs’ departure, consolidating authority more than Warren Buffett had planned. Abel has kept major U.S. holdings largely intact but increased investments in Japanese firms, including a new $1.8 billion stake in Tokio Marine. Recent portfolio trims, such as Apple and Amazon, reflect Buffett’s last quarter in charge.
Rio Tinto stock in focus before London open as results near after Simandou death
Previous Story

Rio Tinto stock in focus before London open as results near after Simandou death

Northern Star shares tick up with gold stocks as traders eye US inflation data
Next Story

Northern Star shares tick up with gold stocks as traders eye US inflation data

Go toTop